La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Toxicologie And NotGeorgy M. Nagy

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000011 Ludmila Juricek [France] ; Xavier Coumoul [France]Alimentation, pesticides et pathologies neurologiques
000C00 Kay Castagnoli [États-Unis] ; Thangaraju Murugesan [États-Unis]Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson's disease and neuroprotection; are there links?
000C01 Moussa B. H. Youdim [Israël] ; Marta Weinstock [Israël]Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation
000C03 Michael A. Collins [États-Unis]Tetrahydropapaveroline in Parkinson's disease and alcoholism: A look back in honor of Merton Sandler
000C19 Toshiharu Nagatsu [Japon]Progress in monoamine oxidase (MAO) research in relation to genetic engineering
000C25 William J. Burke [États-Unis] ; SHU WEN LI [États-Unis] ; Hyung D. Chung [États-Unis] ; David A. Ruggiero [États-Unis] ; Bruce S. Kristal [États-Unis] ; Eugene M. Johnson [États-Unis] ; Patricia Lampe [États-Unis] ; Vijaya B. Kumar [États-Unis] ; Mark Franko [États-Unis] ; Evelyn A. Williams [États-Unis] ; Daniel S. Zahm [États-Unis]Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: Role in neurodegenerative diseases
000C28 Peter Riederer [Allemagne] ; Walter Danielczyk [Autriche] ; Edna Grünblatt [Allemagne]Monoamine oxidase-B inhibition in Alzheimer's disease
000C60 N. Hamaue [Japon] ; M. Minami [Japon] ; M. Terado [Japon] ; M. Hirafuji [Japon] ; T. Endo [Japon] ; M. Machida [Japon] ; T. Hiroshige [Japon] ; A. Ogata [Japon] ; K. Tashiro [Japon] ; H. Saito [Japon] ; S. H. Parvez [France]Comparative study of the effects of isatin, an endogenous MAO-inhibitor, and selegiline on bradykinesia and dopamine levels in a rat model of Parkinson's disease induced by the Japanese encephalitis virus
000C64 JEAN CHEN SHIN [États-Unis]Cloning, after cloning, knock-out mice, and physiological functions of MAO A and B
000C65 Mitsuhiko Yamada [Japon] ; Hajime Yasuhara [Japon]Clinical pharmacology of MAO inhibitors: Safety and future
000C73 Kalman Magyar [Hongrie] ; Béla Szende [Hongrie](-)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024